<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Pasireotide</title><link>https://peptidescanner.com/peptides/pasireotide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Pasireotide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/pasireotide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00171730</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00171730-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00171730-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00171730-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-09-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00171951</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00171951-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00171951-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00171951-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-06-02. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00434148</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00434148-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00434148-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00434148-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-03-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00446082</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00446082-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00446082-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00446082-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-12-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00698464</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00698464-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00698464-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00698464-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-12-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00804336</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00804336-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00804336-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct00804336-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-10-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01128192</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01128192-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01128192-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01128192-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2014-12-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01137682</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01137682-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01137682-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01137682-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-04-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01270321</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01270321-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01270321-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01270321-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-02-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01356862</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01356862-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01356862-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01356862-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-01-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01385956</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01385956-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01385956-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01385956-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-09-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01468532</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01468532-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01468532-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01468532-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-03-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01469572</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01469572-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01469572-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01469572-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-10-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01488487</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01488487-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01488487-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01488487-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-04-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01620138</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01620138-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01620138-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01620138-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-08-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01637272</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01637272-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01637272-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01637272-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-05-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01794793</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01794793-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01794793-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01794793-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-10-01. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01895296</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01895296-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01895296-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct01895296-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-07-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02021942</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02021942-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02021942-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02021942-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-02-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02215070</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02215070-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02215070-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02215070-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-11-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02310269</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02310269-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02310269-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02310269-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-10-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02527993</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02527993-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02527993-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02527993-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-03-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02622906</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02622906-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02622906-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02622906-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-12-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02713776</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02713776-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02713776-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02713776-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-12-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02775227</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02775227-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02775227-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct02775227-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-08-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03103009</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03103009-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03103009-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct03103009-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-09-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03847207</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03847207-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03847207-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct03847207-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-02-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05928390</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05928390-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05928390-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct05928390-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06295952</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06295952-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06295952-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct06295952-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-03-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06456359</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06456359-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06456359-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#clinicaltrials-gov-nct06456359-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-01-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA200677</title><link>https://peptidescanner.com/stories/fda-drugs-nda200677/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda200677:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#fda-drugs-nda200677-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2012-12-14. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2012-25483</title><link>https://peptidescanner.com/stories/federal-register-2012-25483/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2012-25483:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#federal-register-2012-25483-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2012-10-17. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2015-10994</title><link>https://peptidescanner.com/stories/federal-register-2015-10994/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2015-10994:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#federal-register-2015-10994-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2015-05-07. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Treatment of pituitary-dependent Cushing&apos;s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-18957506-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-18957506-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-18957506-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide alone or with cabergoline and ketoconazole in Cushing&apos;s disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20463350-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20463350-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-20463350-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide for the treatment of Cushing&apos;s disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20533892-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20533892-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-20533892-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2014-11-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Management of hyperglycaemia in Cushing&apos;s disease: experts&apos; proposals on the use of pasireotide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23228667-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23228667-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23228667-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide: a review of its use in Cushing&apos;s disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23605695-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23605695-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23605695-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireoride (Signifor) for Cushing&apos;s disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23669783-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23669783-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23669783-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2014-11-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Assessment of the absorption, metabolism and excretion of [¹⁴C]pasireotide in healthy volunteers using accelerator mass spectrometry.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23680921-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23680921-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-23680921-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2014-11-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide and mifepristone: new options in the medical management of Cushing&apos;s disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24126229-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24126229-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-24126229-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-02-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide monotherapy in Cushing&apos;s disease: a single-centre experience with 5-year extension of phase III Trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24287689-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24287689-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-24287689-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Long-term medical treatment of cushing&apos;s disease with pasireotide: a review of current evidence and clinical experience.</title><link>https://peptidescanner.com/stories/pubmed-pmid-25003365-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-25003365-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-25003365-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2014-09-18. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.</title><link>https://peptidescanner.com/stories/pubmed-pmid-25613083-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-25613083-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-25613083-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26275531-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26275531-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-26275531-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-02-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide for the treatment of acromegaly.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26808354-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26808354-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-26808354-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27473537-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27473537-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-27473537-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Insulin sensitivity and secretion and adipokine profile in patients with Cushing&apos;s disease treated with pasireotide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29396758-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29396758-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-29396758-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-01-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29534939-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29534939-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-29534939-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-02-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>How to Position Pasireotide LAR Treatment in Acromegaly.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30608534-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30608534-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-30608534-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-05-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32843370-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32843370-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-32843370-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-08-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35518928-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35518928-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-35518928-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-11-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pituitary acting drugs: cabergoline and pasireotide.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35670988-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35670988-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-35670988-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Second line treatment of acromegaly: Pasireotide or Pegvisomant?</title><link>https://peptidescanner.com/stories/pubmed-pmid-35931640-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35931640-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-35931640-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-12-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing&apos;s disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38577574-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38577574-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38577574-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-06-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38713182-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38713182-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38713182-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38817802-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38817802-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38817802-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-06-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38982703-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38982703-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-38982703-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-07-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Management of Diabetes Mellitus in Acromegaly and Cushing&apos;s Disease with Focus on Pasireotide Therapy: A Narrative Review.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39072348-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39072348-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-39072348-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-07-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39129819-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39129819-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-39129819-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-08-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Real-World Experience with Pasireotide-LAR in Cushing&apos;s Disease: Single-Center 12-Month Observational Study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-40283624-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-40283624-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-40283624-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-04-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Real-life data on pasireotide in monotherapy or combined in active Cushing&apos;s disease.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41323967-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41323967-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-41323967-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-12-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42778805-pasireotide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42778805-pasireotide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/pasireotide.json#pubmed-pmid-42778805-pasireotide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
